Healthcare Professionals Investor Login Turkish

Alzheimer

Scientific Documents
Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models
Recent News
Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026
Patents
Parbendazole For Use In The Treatment Of Dementia - PCT
Patents
Treatment of Dementia Using Bortezomib or Parbendazole - EPO
Scientific Documents
Drug Repositioning Targeting Glutaminase Reveals Drug Candidates for The Treatment of Alzheimer’s Disease Patients
Scientific Documents
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis